Pharmacological treatment of obesity in patients with polycystic ovary syndrome
- PMID: 21197149
- PMCID: PMC3010652
- DOI: 10.1155/2011/402052
Pharmacological treatment of obesity in patients with polycystic ovary syndrome
Abstract
Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk. Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese. Over the last 20 years, the prevalence of obesity has dramatically increased, with probable associated increase in PCOS. Weight reduction plays an integral part in the management of women with PCOS. In this paper, current available weight reduction therapies in the management of PCOS are discussed.
Figures
Similar articles
-
The role of obesity in the development of polycystic ovary syndrome.Curr Pharm Des. 2012;18(17):2482-91. doi: 10.2174/13816128112092482. Curr Pharm Des. 2012. PMID: 22376149 Review.
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2. Endocr Pract. 2015. PMID: 26642102 Review.
-
New Therapeutic Approaches in Obesity and Metabolic Syndrome Associated with Polycystic Ovary Syndrome.Cureus. 2017 Nov 13;9(11):e1844. doi: 10.7759/cureus.1844. Cureus. 2017. PMID: 29344438 Free PMC article. Review.
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC. Endocr Pract. 2015. PMID: 26509855
-
Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.J Obstet Gynaecol. 2019 Oct;39(7):975-980. doi: 10.1080/01443615.2019.1581754. Epub 2019 May 7. J Obstet Gynaecol. 2019. PMID: 31064233
Cited by
-
The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study.Front Endocrinol (Lausanne). 2014 Aug 27;5:140. doi: 10.3389/fendo.2014.00140. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 25221543 Free PMC article.
-
Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms.J Endocrinol Invest. 2016 May;39(5):567-76. doi: 10.1007/s40618-015-0423-3. Epub 2016 Jan 7. J Endocrinol Invest. 2016. PMID: 26742935
-
The Effect of Phytoestrogen on Thyroid in Subclinical Hypothyroidism: Randomized, Double Blind, Crossover Study.Front Endocrinol (Lausanne). 2018 Sep 11;9:531. doi: 10.3389/fendo.2018.00531. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30254609 Free PMC article.
References
-
- Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology and Metabolism. 2004;89(6):2745–2749. - PubMed
-
- Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: a prospective study. Journal of Clinical Endocrinology and Metabolism. 1998;83(9):3078–3082. - PubMed
-
- Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek Island of Lesbos: hormonal and metabolic profile. Journal of Clinical Endocrinology and Metabolism. 1999;84(11):4006–4011. - PubMed
-
- Asunción M, Calvo RM, San Millá N JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology and Metabolism. 2000;85(7):2434–2438. - PubMed
-
- Balen AH, Conway GS, Kaltsas G, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Human Reproduction. 1995;10(8):2107–2111. - PubMed
LinkOut - more resources
Full Text Sources